| Key Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
-0.27 |
-157.48 |
-6.17 |
-16.29 |
68.86 |
|
| Diluted EPS (Rs.) |
-0.27 |
-157.48 |
-6.17 |
-16.29 |
68.86 |
|
| Cash EPS (Rs.) |
24.39 |
-128.84 |
24.64 |
14.85 |
91.67 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
272.35 |
260.39 |
417.54 |
424.18 |
443.42 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
272.35 |
260.39 |
417.54 |
424.18 |
443.42 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
7.00 |
|
| Revenue from Operations/Share (Rs.) |
318.95 |
358.03 |
401.06 |
352.32 |
450.13 |
|
| PBDIT/Share (Rs.) |
52.91 |
-24.91 |
43.38 |
27.53 |
115.18 |
|
| PBIT/Share (Rs.) |
28.26 |
-53.53 |
12.58 |
-3.58 |
85.03 |
|
| PBT/Share (Rs.) |
-0.27 |
-135.65 |
-12.44 |
-25.46 |
61.51 |
|
| Net Profit/Share (Rs.) |
-0.27 |
-157.46 |
-6.17 |
-16.27 |
61.51 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
16.59 |
-6.95 |
10.81 |
7.81 |
25.58 |
|
| PBIT Margin (%) |
8.85 |
-14.95 |
3.13 |
-1.01 |
18.89 |
|
| PBT Margin (%) |
-0.08 |
-37.88 |
-3.10 |
-7.22 |
13.66 |
|
| Net Profit Margin (%) |
-0.08 |
-43.98 |
-1.53 |
-4.61 |
13.66 |
|
| Return on Networth / Equity (%) |
-0.09 |
-60.47 |
-1.47 |
-3.83 |
13.87 |
|
| Return on Capital Employed (%) |
8.83 |
-17.37 |
2.51 |
-0.68 |
16.73 |
|
| Return on Assets (%) |
-0.04 |
-24.15 |
-0.76 |
-1.98 |
8.46 |
|
| Total Debt/Equity (X) |
0.71 |
1.07 |
0.67 |
0.67 |
0.32 |
|
| Asset Turnover Ratio (%) |
0.56 |
0.49 |
0.49 |
0.46 |
61.94 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.78 |
0.64 |
1.09 |
1.16 |
1.35 |
|
| Quick Ratio (X) |
0.44 |
0.35 |
0.58 |
0.62 |
0.97 |
|
| Inventory Turnover Ratio (X) |
1.72 |
1.66 |
1.37 |
1.97 |
5.48 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
-18.40 |
8.93 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
20.16 |
5.99 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
118.40 |
91.07 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
79.84 |
94.01 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
3,235.77 |
2,331.72 |
2,174.68 |
3,371.97 |
5,325.48 |
|
| EV/Net Operating Revenue (X) |
2.21 |
1.81 |
1.51 |
2.66 |
3.29 |
|
| EV/EBITDA (X) |
13.31 |
-26.00 |
13.92 |
34.02 |
12.87 |
|
| MarketCap/Net Operating Revenue (X) |
1.61 |
1.04 |
0.82 |
1.89 |
3.10 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
118.40 |
91.06 |
|
| Price/BV (X) |
1.88 |
1.43 |
0.79 |
1.57 |
3.14 |
|
| Price/Net Operating Revenue |
1.61 |
1.04 |
0.82 |
1.89 |
3.10 |
|
| Earnings Yield |
0.00 |
-0.42 |
-0.02 |
-0.02 |
0.04 |
|
Source : Dion Global Solutions Limited
